Ginkgo Bioworks Holdings (DNA) Acquisitions (2021 - 2024)

Ginkgo Bioworks Holdings (DNA) reported Acquisitions of $5.4 million for Q1 2024, up 157.8% quarter-over-quarter from -$9.3 million in Q4 2021.

Ginkgo Bioworks Holdings (DNA) Acquisitions (2021 - 2024) Analysis & Trends

Ginkgo Bioworks Holdings has reported Acquisitions for 2 years, with the latest figure at $5.4 million in Q1 2024.

For the quarter ending Q1 2024, Acquisitions changed N/A year-over-year to $5.4 million; the trailing twelve-month figure through Dec 2024 stood at $5.4 million (changed N/A YoY), and the FY2024 full-year result was $5.4 million, changed N/A from the prior year.
Acquisitions for Q1 2024 stood at $5.4 million, up from -$9.3 million in the prior quarter.
The five-year high for Acquisitions was $20.2 million in Q3 2021, with the low at -$9.3 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Ginkgo Bioworks Holdings	546.79 Mn	546.79 Mn	16.38 Mn	-

Download Data